logo
Plus   Neg
Share
Email

Johnson Controls Re-initiates FY20 Adj. EPS Outlook, Above Estimates - Quick Facts

While reporting financial results for the third quarter on Friday, Johnson Controls International plc (JCI) provided adjusted earnings and organic revenue growth guidance for the fourth quarter and re-initiated adjusted earnings outlook for the full-year 2020.

For the fourth quarter, the company projects adjusted earnings in a range of $0.68 to $0.72 per share on organic revenue decline of 9 to 11 percent.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $0.65 per share on a revenue decline of 20.5 percent to $5.44 billion for the quarter. Analysts' estimates typically exclude special items.

Looking ahead to fiscal 2020, the company re-initiated adjusted earnings guidance in the range of $2.16 to $2.20 per share, representing a year-over-year increase of 10 to 12 percent. The Street is looking for earnings of $1.93 per share on a revenue decline of 9.7 percent to $21.64 billion for the year.

The company had withdrawn its previously communicated fiscal year 2020 guidance in early May, as a result of the challenging and uncertain macro environment attributable to the impact the novel coronavirus (COVID-19) pandemic.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Las Vegas, Nevada-based Mr. Wok Foods has recalled about 200,000 pounds of meat and poultry products for misbranding and undeclared allergens, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS said. The recalled products may contain known allergens such as milk, wheat, soy, peanuts, or oysters. They may also contain MSG, sesame products, or sulfites. The U.S. Food and Drug Administration approved the first oral drug to treat patients two months of age and older with spinal muscular atrophy (SMA) that can be taken at home. Roche subsidiary Genentech's Evrysdi (risdiplam) is also the second FDA-approved drug to treat this rare and often fatal genetic disease affecting muscle strength and movement. Supermarket chain Wegmans Food Markets, Inc. is recalling select Valencia oranges, lemons, and various other products containing fresh lemon citing potential contamination with Listeria monocytogenes, the U.S. Food and Drug Administration announced. The recall was initiated after Wegmans' lemons and oranges supplier Freshouse Produce LLC, issued a recall of its supplies.
Follow RTT